您的位置:PharmaNews 研发动态 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Basilea Pharmaceutica AG (CH) - Data on Basilea's Toctino in Daily Medical Practice in Germany Presented at Dermatology Congress(3)
本文章共3575字,分3页,当前第3页,快速翻页:

For further information, please contact:

Media Relations

Investor Relations

Adesh Kaul Head Public Relations & Corporate Communications +41 61 606 1460 media_relations@basilea.com

Barbara Zink, Ph.D., MBA Head Corporate Development

+41 61 606 1233 investor_relations@basilea.com

 

 转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  Orexigen Therapeutics Announces Publicat

  Geron to Proceed with First Human Clinic

  Bionovo to Advance Menerba to Phase 3 Cl

  deCODE Shows how Genetic Risk of Kidney

  New pathway to Parkinson's and Alzheimer

  Plant Compound Resveratrol Shown to Supp

  WaferGen Announces Purchase of SmartChip

  Researchers Solve Mystery of Uner Tan Sy

  Shionogi Inc. Announces FDA Approval of

  Abraxis BioScience and Specialised Thera

Study Results Show That Oral Contracepti

勃林格殷格翰糖尿病药物linagliptin一项Ⅲ期

厄洛替尼在欧盟提交申请用于具EGFR 活化突变

诺华公司肾癌治疗药物依维莫司新适应证研究

罗氏发布在研糖尿病药taspoglutide的Ⅲ期临

罗氏正式提交赫赛汀第二代共轭化合物曲妥珠

达沙替尼申请用于慢性髓性白血病一线治疗

动脉血管瘤支架有望成为新一代畅销介入治疗

相关评论

    
本文章所属分类:首页 研发动态